Stay updated on Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.

Latest updates to the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new site revision label Revision: v3.4.2 was added and an older funding notice was removed. There are no changes to core trial data, eligibility criteria, endpoints, or listed locations; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check22 days agoChange DetectedAdded a site-wide notice about a lapse in government funding, informing users that information may not be up to date and transactions may not be processed, with links to cc.nih.gov and opm.gov. The page revision is updated to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check29 days agoChange DetectedShow glossary has been added; UI labels have been standardized, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the page revision is now 'Revision: v3.4.0'. These changes replace the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check43 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be a minor system revision and does not alter the study details or visible page content.SummaryDifference0.1%

- Check64 days agoChange DetectedLocations for Paraná, Rio Grande do Sul, and São Paulo were added. The dedicated Paraná Locations, Rio Grande do Sul Locations, and São Paulo Locations sections were removed, and the revision updated to v3.3.3.SummaryDifference0.4%

- Check93 days agoChange DetectedThe revision label in the footer changed from 'Revision: v3.2.0' to 'Revision: v3.3.2'.SummaryDifference0.1%

Stay in the know with updates to Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.